Samuel Moed
Director/Board Member at SCINAI IMMUNOTHERAPEUTICS LTD.
Net worth: - $ as of 30/03/2024
Profile
Samuel J.
Moed is currently a Director at Scinai Immunotherapeutics Ltd.
Previously, he held positions as an Independent Director at MediWound Ltd., Senior VP-Strategic Planning & Analysis at Bristol Myers Squibb Co., President at US Pharmaceuticals, Inc., and President at Worldwide Consumer Health Care.
He received his undergraduate degree from The Trustees of Columbia University in The City of New York in 1985.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 14/03/2023 | 0 ( -.--% ) | - $ | 30/03/2024 |
Samuel Moed active positions
| Companies | Position | Start |
|---|---|---|
| SCINAI IMMUNOTHERAPEUTICS LTD. | Director/Board Member | 23/03/2020 |
Former positions of Samuel Moed
| Companies | Position | End |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 31/12/2019 |
US Pharmaceuticals, Inc.
 US Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology US Pharmaceuticals, Inc. manufactures and distributes medicines. The private company is based in Seal Beach, CA. | President | - |
| Worldwide Consumer Health Care | President | - |
| MEDIWOUND LTD. | Director/Board Member | - |
Training of Samuel Moed
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MEDIWOUND LTD. | Health Technology |
| SCINAI IMMUNOTHERAPEUTICS LTD. | Health Technology |
| Private companies | 2 |
|---|---|
US Pharmaceuticals, Inc.
US Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology US Pharmaceuticals, Inc. manufactures and distributes medicines. The private company is based in Seal Beach, CA. | Health Technology |
| Worldwide Consumer Health Care |
- Stock Market
- Insiders
- Samuel Moed
